Advertisement
Canada markets close in 5 hours 58 minutes

  • S&P/TSX

    21,989.58
    -22.14 (-0.10%)
     

  • S&P 500

    5,079.12
    +8.57 (+0.17%)
     

  • DOW

    38,477.88
    -25.81 (-0.07%)
     

  • CAD/USD

    0.7296
    -0.0024 (-0.33%)
     

  • CRUDE OIL

    82.89
    -0.47 (-0.56%)
     

  • Bitcoin CAD

    90,512.61
    -683.63 (-0.75%)
     

  • CMC Crypto 200

    1,429.17
    +5.07 (+0.36%)
     

  • GOLD FUTURES

    2,333.80
    -8.30 (-0.35%)
     

  • RUSSELL 2000

    2,003.80
    +1.15 (+0.06%)
     

  • 10-Yr Bond

    4.6460
    +0.0480 (+1.04%)
     

  • NASDAQ

    15,792.53
    +95.89 (+0.61%)
     

  • VOLATILITY

    15.72
    +0.03 (+0.19%)
     

  • FTSE

    8,065.30
    +20.49 (+0.25%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6822
    -0.0014 (-0.20%)
     
MARKETS LIVE BLOG:

STOCKS OPEN MIXED, TESLA SURGES DAY AFTER EARNINGS

Tesla shares jump after EV maker vows to speed up launch of more affordable models

Today's Research Reports on Hemostemix, Cotinga Pharmaceuticals, Emerald Health Therapeutics and DiaMedica Therapeutics

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / July 23, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI Initiates Coverage on:

Hemostemix Inc.
https://rdinvesting.com/news/?ticker=HEM.V

Cotinga Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=COT.V

Emerald Health Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=EMH.V

DiaMedica Therapeutics Inc.
https://rdinvesting.com/news/?ticker=DMA.V

ADVERTISEMENT

Hemostemix's stock moved 7.14% lower Friday, to close the day at $0.065. The stock recorded a trading volume of 6,000 shares, which was below its three months average volume of 228,665 shares. In the last year, Hemostemix's shares have traded in a range of 0.05 - 0.16. The share price has gained 44.44% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.08 is greater than its 200-day moving average of $0.07. Shares of Hemostemix have fallen approximately 7.14 percent year-to-date.

Access RDI's Hemostemix Inc. Research Report at:
https://rdinvesting.com/news/?ticker=HEM.V

On Friday, shares of Cotinga Pharmaceuticals recorded a trading volume of 16,700 shares, which was above the three months average volume of 15,414 shares. The stock ended the day 44.74% higher at 0.55. The share price has gained 89.66% from its 52-week low with a 52-week trading range of 0.29 - 1.88. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.49 is below its 200-day moving average of $0.63. Shares of Cotinga Pharmaceuticals have fallen approximately 60.91 percent year-to-date.

Access RDI's Cotinga Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=COT.V

Emerald Health Therapeutics' stock edged 0.38% lower Friday, to close the day at $2.59. The stock recorded a trading volume of 591,528 shares, which was below its three months average volume of 681,266 shares. In the last year, Emerald Health Therapeutics' shares have traded in a range of 1.10 - 25.06. The share price has gained 135.45% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $3.67 is below its 200-day moving average of $5.09. Shares of Emerald Health Therapeutics have fallen approximately 50.29 percent year-to-date.

Access RDI's Emerald Health Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=EMH.V

On Friday, shares of DiaMedica Therapeutics recorded a trading volume of 633,923 shares, which was above the three months average volume of 195,846 shares. The stock ended the day 25.71% lower at 0.52. The share price has gained 147.62% from its 52-week low with a 52-week trading range of 0.21 - 0.90. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.70 is greater than its 200-day moving average of $0.49. Shares of DiaMedica Therapeutics have gained approximately 124.14 percent year-to-date.

Access RDI's DiaMedica Therapeutics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=DMA.V

Our Actionable Research on Hemostemix Inc. (TSXV:HEM.V) and Cotinga Pharmaceuticals Inc. (TSXV:COT.V) and Emerald Health Therapeutics, Inc. (TSXV:EMH.V) and DiaMedica Therapeutics Inc. (TSXV:DMA.V) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com